There is no Press for this Ticker
Sector: Health Care.Industry: Life Sciences Tools & Services
RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendon injuries, androgenetic alopecia, and skin aging. Its development program of the company is based on distinct technology that utilizes cells isolated from a patient's healthy hair follicles. Also, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company use autologous cell therapy which is developed for the treatment of androgenetic alopecia. The revenue is generated from Licensing fees.

Related Companies

TickerCompanyChg %Mkt Cap
REPCFRepliCel Life Sciences-1.06%10.1M

RepliCel Life Sciences Company Questions & Answers

Q

How do I buy RepliCel Life Sciences (REPCF) stock?

A

You can purchase shares of RepliCel Life Sciences (OTC: REPCF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are RepliCel Life Sciences's (REPCF) main competitors?

A

There are no as such competitors for RepliCel Life Sciences.

Q

What is the target price for RepliCel Life Sciences?

A

There is no analysis for RepliCel Life Sciences

Q

How much is RepliCel Life Sciences (REPCF) stock ?

A

The stock price for RepliCel Life Sciences (OTC: REPCF) is $0.28 last updated Fri May 07 2021 18:40:57 GMT+0000 (Coordinated Universal Time).

Q

When is the next RepliCel Life Sciences (REPCF) dividend?

A

There are no upcoming dividends for RepliCel Life Sciences.

Q

When is RepliCel Life Sciences (OTC:REPCF) reporting earnings?

A

There are no earnings for RepliCel Life Sciences

Q

When is the upcoming split for REPCF?

A

There is no upcoming split for RepliCel Life Sciences.